The Drugs Controller General of India (DCGI), on Sunday, has approved Bharat Biotech’s Covaxin and Oxford-AstraZeneca vaccines for emergency usage. These are the first-ever vaccines that will be used in the country to fight COVID-19.
The overall efficacy of the Oxford-AstraZeneca Covid-19 vaccine was 70.42%, while Bharat Biotech’s Covaxin was “safe and provides a robust immune response”, DCGI’s VG Somani said.
He added that they wouldn’t approve vaccine if it is not a hundred per cent safe. He also added that the vaccine does have some side effects like mild fever, pain which are very common.
“We’ll never approve anything if there is slightest of safety concern. The vaccines are 100% safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It (people may get impotent) is absolute rubbish,” VG Somani said.
